In another study evaluating the contribution of RAD51 genes, small proportions of pathogenic mutations in RAD51C (14/3429, 0.41%) and RAD51D (12/3429, 0.35%) in invasive epithelial ovarian cancer were identified (Song et al., 2015). This evidence concerns the gene RAD51D and ovarian carcinoma.